Leading commercialization and growth strategy for Adhere+, a proven Remote Therapeutic Monitoring (RTM) SaaS platform that improves patient outcomes, reduces provider burden, and drives financial sustainability. I oversee brand positioning, market differentiation, and go-to-market initiatives across key verticals, including pain management, bariatrics, mental health, and chronic care. Focused on building a strong digital presence, KOL engagement, and scalable marketing programs to establish Adhere+ as the leading Clinical Data Analytics Company (C-DAC) for real-world evidence and predictive analytics.

- Founded a consultancy focused on empowering medtech startups to articulate their value proposition, leveraging clinical and technological advancements to secure market positioning. - Advised clients across various sectors, including digital therapeutics and neuromodulation, driving strategic initiatives that accelerated growth and market entry.

- Spearheaded the commercialization of a novel micro-stimulation platform, achieving significant market penetration in the competitive $3-bil chronic pain industry through strategic use of account-based marketing techniques to personalize customer engagement and enhance stakeholder relationships.- Engineered a multi-channel marketing strategy, incorporating advanced digital marketing tactics to enhance brand visibility and drive product adoption among key stakeholders, resulting in a doubling of revenue YoY in first three years of commercialization.- Pioneered the creation of a professional education community, fostering belonging and loyalty among users, which facilitated deeper customer adoption and created brand advocates. Led a dynamic marketing team, fostering collaboration and innovation, to launch 7 key products, significantly impacting company revenue and positioning Nalu as a market leader in Peripheral Nerve Stimulation. - Utilized data-driven insights to optimize initiatives for high ROI, aligning with corporate goals and driving sustainable growth.

- Pioneered global marketing strategies for the launch of a groundbreaking closed-loop spinal cord stimulator, establishing Saluda Medical as a key player in the EU and Australian markets.- Developed and executed comprehensive marketing communications and product management plans, contributing to the company's rapid international expansion.

- Led the revitalization of the commercial team, establishing core marketing and sales strategies that significantly enhanced branding and market positioning.- Directed the development and execution of innovative sales models and marketing plans, aligning with clinical objectives to drive market development and adoption of virtual reality (VR) programs in surgical planning, navigation, and patient education.

(As of May 2015, Spinal Modulation was acquired St. Jude Medical.* Manage DRG stimulation business (Spinal Modulation) transfer & integration involving Product Marketing & Management, Marketing Communication & Training.* Analyze, develop, & deploy competitive marketing initiatives for US chronic pain market.* Strategize & lead SJM Neuromodulation congress programs (NANS 2015: 1600+ attendees)

- Directed downstream marketing for Europe and Australia, scaling from zero sales to over $50 million by acquisition.- Designed commercial branding and developed campaigns to identify treatable patient populations, fostering therapy adoption and opening referral pathways.- Led scientific conference planning and KOL engagement, contributing to the strategic positioning of the company.- Served as a Field Clinical Engineer and Trainer while managing two study centers during the closing phase of the US/IDE ACCURATE Clinical Study, achieving 175% to plan for patient enrollment.

- Managed DRG stimulation systems, leading product forecasting, strategic labeling, and VOC initiatives to enhance market adoption.

* Responsible for product management activities related to Leads, Accessories, & Enabling Technologies within Deep Brain Stimulation (DBS) division.* Product/Therapy Training & Support –international & domestic markets (EU, AUS, & North America)* B2B – Oversaw B2B relations to provide integrated therapy solutions for customers (stereotactic surgical navigation & microelectrode recording systems).

* Managed international & domestic (US) neuromodulation research studies in clinical & in-vivo models. Projects spanned both SCS & DBS. * Responsible for KOL/investigator management , study design and initiation, & presentation.* Technical & research advisor to external physicians & scientists.

* Thesis Research – Dynamic control of the larynx by nerve stimulation in a canine model.-- Primary surgeon, biological signal acquisition, experimental equipment design & data analysis.* Assisting Researcher – Phase I Clinical Trials to evaluate stimulator to reduce post-stroke aspiration.-- Clinical engineer/technical advisor during patient implants & trials